Role of transforming growth factor β type II receptor in hepatic fibrosis: Studies of human chronic hepatitis C and experimental fibrosis in rats

Hepatology

Volumn 29, Issue 6, 1999, Pages 1730-1738

  Roulot, D ^a   Sevcsik, A M ^a   Coste, T ^a   Strosberg, A D ^a   Marullo, S ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CORRELATION FUNCTION; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

EID: 0033036099     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290622     Document Type: Article

References (46)

1. 1 Nakatsukasa H, Evarts RP, Hsia C, Thorgeirsson S. Transforming growth factor β 1 and type I procollagen transcripts during regeneration and early fibrosis in rat liver. Lab Invest 1990 ; 63: 171–180. MEDLINE
2. 2 Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell‐specific expression of transforming growth factor‐beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest 1995 ; 96: 447–455. MEDLINE
3. 3 Maher JJ, McGuire R. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990 ; 86: 1641–1648. MEDLINE
4. 4 Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat‐storing cells in fibrogenesis. Semin Liver Dis 1990 ; 10: 30–46. MEDLINE
5. 5 Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast‐like cells. J Clin Invest 1992 ; 89: 19–27. MEDLINE
6. 6 Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell–derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990 ; 11: 599–605. MEDLINE
7. 7 Polyak K. Negative regulation of cell growth by TGF beta. Biochim Biophys Acta 1996 ; 1242: 185–199. MEDLINE
8. 8 Russell WE, Coffey JRJ, Quellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci U S A 1988 ; 85: 5126–5130. MEDLINE
9. 9 Massague J. The transforming growth factor beta family. Annu Rev Cell Biol 1990 ; 6: 597–641. MEDLINE
10. 10 Massague J. Receptors for the TGF‐β family. Cell 1992 ; 69: 1067–1070. MEDLINE
11. 11 Derynck R. TGF‐beta‐receptor–mediated signaling. Trends Biochem Sci 1994 ; 19: 548–553. MEDLINE
12. 12 Franzen P, Ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 1993 ; 75: 681–692. MEDLINE
13. 13 Ebner R, Chen RH, Shum L, Lawler S, Zioncheck TF, Lee A, Lopez AR, Derynck R. Cloning of a type‐I TGF‐beta receptor and its effect on TGF‐beta binding to the type‐II receptor. Science 1993 ; 260: 1344–1348. MEDLINE
14. 14 ten Dijke P, Yamashita H, Ichijo H, Franzen P, Laiho M, Miyazono K, Heldin C‐H. Characterization of type I receptors for transforming growth factor‐β and activin. Science 1994 ; 264: 101–104. MEDLINE
15. 15 Lin HY, Wang XF, Ng‐Eaton E, Weinberg RA, Lodish HF. Expression cloning of the TGF‐β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992 ; 68: 775–785. MEDLINE
16. 16 Wang X‐F, Lin HY, Ng‐Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TGFβ type III receptor. Cell 1991 ; 67: 797–805. MEDLINE
17. 17 Lin HY, Moustakas A, Knaus P, Wells RG, Henis YI, Lodish HF. The soluble exoplasmic domain of the type II transforming growth factor (TGF)‐β receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF‐β ligands. J Biol Chem 1995 ; 270: 2747–2754. MEDLINE
18. 18 Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, et al. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 1992 ; 71: 1003–1014. MEDLINE
19. 19 Moustakas A, Lin HY, Henis YI, Plamondon J, O'Connor‐McCourt MD, Lodish H. The transforming growth factor β receptors types I, II, and III form hetero‐oligomeric complexes in the presence of ligand. J Biol Chem 1993 ; 268: 22215–22218. MEDLINE
20. 20 Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF‐beta receptor. Nature 1994 ; 370: 341–347. MEDLINE
21. 21 Chen RH, Ebner R, Derynck R. Inactivation of the type‐II receptor reveals two receptor pathways for the diverse TGF‐β activities. Science 1993 ; 260: 1335–1338. MEDLINE
22. 22 Wieser R, Attisano L, Wrana JL, Massague J. Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol 1993 ; 13: 7239–7247. MEDLINE
23. 23 Feng XH, Filvaroff EH, Derynck R. Transforming growth factor‐beta (TGF‐beta)‐induced down‐regulation of cyclin A expression requires a functional TGF‐beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J Biol Chem 1995 ; 270: 24237–24245. MEDLINE
24. 24 Knodell RG, Ishak KG, Black WC, Chen TS, Greg R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 ; 1: 431–435. MEDLINE
25. 25 Chomczynski P, Sacchi N. Single‐step method of RNA isolation by acidic guanidium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 1987 ; 162: 156–159. MEDLINE
26. 26 Krief S, Lönnqvist F, Raimbault S, Baude B, Van Spronsen A, Arner P, Strosberg AD, Emorine LJ. Tissue distribution of β3‐adrenergic receptors mRNA in man. J Clin Invest 1993 ; 91: 344–349. MEDLINE
27. 27 Becker‐André M, Hahlbrock K. Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res 1989 ; 17: 9437–9446. MEDLINE
28. 28 Roulot D, Durand H, Coste T, Rautureau J, Strosberg AD, Benarous R, Marullo S. Quantitative analysis of TGFβ1 mRNA in the liver of patients with chronic hepatitis C: absence of correlation between high levels and severity of disease. Hepatology 1995 ; 21: 298–304. MEDLINE
29. 29 PRacine‐Samson L, Rockey DC, Bissell DM. The role of alpha1 beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem 1997 ; 272: 30911–30917. MEDLINE
30. 30 Genovese C, Rowe D, Kream B. Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25‐dihydroxyvitamin D. Biochemistry 1984 ; 23: 6210–6216. MEDLINE
31. 31 Jarnagin WR, Rockey DC, Koteliansky VE, Bissell DM. Expression of variant fibronectin in wound‐healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994 ; 127: 2037–2048. MEDLINE
32. 32 Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997 ; 94: 1441–1446. MEDLINE
33. 33 Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. N Engl J Med 1991 ; 324: 933–940. MEDLINE
34. 34 Roulot D, Bissell DM. Expression of the transforming growth factor‐beta type I receptor in rat hepatic fibrogenesis. Hepatology 1997 ; 26: 370A.
35. 35 Derynck R, Feng XH. TGF‐beta receptor signaling. Biochim Biophys Acta 1997 ; 1333: F105–150. MEDLINE
36. 36 Friedman SL, Yamasaki G, Wong L. Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response—enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem 1994 ; 269: 10551–10558. MEDLINE
37. 37 Bachem MG, Riess U, Gressner AM. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth alpha and inhibited by transforming growth factor β. Biochem Biophys Res Commun 1989 ; 162: 708–714. MEDLINE
38. 38 Roth S, Michel K, Gressner AM. (Latent) transforming growth factor beta in liver parenchymal cells, its injury‐dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 1998 ; 27: 1003–1012. MEDLINE
39. 39 Nakatsukasa H, Nagy P, Evarts RP, Hsia C, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor β1 and procollagen type I, III and IV transcripts in carbon tetrachloride–induced rat liver fibrosis. J Clin Invest 1990 ; 85: 1833–1843. MEDLINE
40. 40 Sue SR, Chari RS, Kong FM, Mills JJ, Fine RL, Jirtle RL, Meyers WC. Transforming growth factor beta receptors and mannose 6‐phosphate/insulin like growth factor‐II receptor expression in human hepatocellular carcinoma. Ann Surg 1995 ; 222: 171–178. MEDLINE
41. 41 Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor‐beta 1 (TGF‐beta 1) and TGF‐beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995 ; 21: 760–766. MEDLINE
42. 42 Suzuki A, Shioda N, Maeda T, Tada M, Ueno N. A mouse TGF‐beta type I receptor that requires type II receptor for ligand binding. Biochem Biophys Res Commun 1994 ; 198: 1063–1069. MEDLINE
43. 43 Massague J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 1996 ; 85: 947–950. MEDLINE
44. 44 McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, Bush HLJ. Decreased type II/type I TGFβ receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGFβ1. J Clin Invest 1995 ; 96: 2667–2675. MEDLINE
45. 45 Akiyama Y, Iwanaga R, Saitoh K, Shiba K, Ushio K, Ikeda E, Iwama T, et al. Transforming growth factor β type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 1997 ; 112: 33–39. MEDLINE
46. 46 Wrana JL, Attisano L. MAD‐related proteins in TGF‐beta signalling. Trends Genet 1996 ; 12: 493–496. MEDLINE